Obinutuzumab in Treatment of Fibrillary Glomerulonephritis

Clinical trial NCT06295770 · RECRUITING

Trial details

NCT number: NCT06295770
Sponsor: Mayo Clinic
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Fibrillary Glomerulonephritis

Start date: 2024-06-24
Primary completion: 2026-12-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.